封面
市場調查報告書
商品編碼
1807707

細胞株開發的全球市場:規模,佔有率,趨勢,產業分析報告:各類產品·服務,供給來源,各細胞株類型,各用途,各地區 - 市場預測(2025年~2034年)

Cell Line Development Market Size, Share, Trends, & Industry Analysis Report By Product & Service, By Source, By Type of Cell Lines, By Application, and By Region - Market Forecast, 2025-2034

出版日期: | 出版商: Polaris Market Research | 英文 125 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究,預計到 2034 年,全球細胞株開發市場規模將達到 154.3 億美元。本報告深入分析了當前的市場動態,並分析了未來的市場成長。

細胞株開發涉及創建和選擇用於生物製藥生產、疫苗開發和藥物篩選的穩定細胞株,以確保高生產率、遺傳穩定性和一致的療效。隨著製藥和生物技術公司擴大採用先進的細胞株工程技術來加速生物製藥開發、降低生產成本並提高產品質量,細胞株開發市場持續擴張。

全球對重組蛋白和細胞疫苗日益增長的需求推動了市場的成長。腫瘤學、傳染病和個人化醫療領域研發支出的不斷增長,推動了創新細胞系工程技術的應用,例如 CRISPR 基因編輯和一次性生物反應器。此外,對生物製藥生產基礎設施的投資不斷增加,以及與專業合約研發生產組織 (CDMO) 建立策略性外包合作夥伴關係,正在促進全球治療性生物製劑的大規模生產。

細胞系開發市場報告重點

按產品/服務劃分,試劑和培養基細分市場預計將在 2024 年佔最大市場份額。這得益於對高品質、化學成分明確的培養基日益增長的需求,這些培養基可增強生物製藥生產中的細胞生長、穩定性和生產力。

依供應來源劃分,哺乳動物細胞系細分市場佔市場主導地位。這是因為其對複雜治療性蛋白質的生產效率高,從而確保了生物製藥生產中更高的功效和安全性。

以細胞系類型劃分,雜交瘤細分市場預計將成長最快。這是由於腫瘤學、自體免疫學和傳染病治療對單株抗體生產的需求不斷增長,以及雜交瘤篩選和選擇技術的進步。

按應用劃分,生物生產領域在2024年佔主導地位,這得益於穩定細胞系在重組蛋白、生物相似藥和疫苗大規模生產中的日益普及。

在先進的製造基礎設施以及大型生物技術公司和CDMO的推動下,北美在2024年主導了全球細胞系開發市場。

由於生物製藥行業的快速擴張以及向中國和印度等具有成本效益的市場外包細胞系開發服務的數量增加,亞太地區經歷了穩步增長。

全球主要市場參與者包括龍沙集團、藥明生物、賽默飛世爾科技、賽多利斯、Charles River Laboratories、默克、Cytovance Biologics、Cellistic、Berkeley Lights、Advance Instruments、丹納赫集團和Creative Biolabs。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球細胞株開發市場洞察

  • 市場概況
  • 細胞株開發市場動態
    • 驅動因素與機遇
      • 全球癌症病例不斷增加
      • 全球研發支出不斷增加
    • 限制與挑戰
      • 高成本且漫長的開發流程
  • PESTEL 分析
  • 細胞株開發市場趨勢
  • 價值鏈分析

第5章 全球細胞株開發市場:各類產品·服務

  • 主要調查結果
  • 簡介
  • 試劑·培養基
  • 設備
  • 配件與消耗品
  • 毒性實驗

第6章 全球細胞株開發市場:供給來源

  • 主要調查結果
  • 簡介
  • 哺乳類細胞株
  • 非哺乳類細胞株

第7章 全球細胞株開發市場:各細胞株類型

  • 主要調查結果
  • 簡介
  • 重組細胞株
  • 融合瘤
  • 常用細胞株
  • 第一代細胞株

第8章 全球細胞株開發市場:各用途

  • 主要調查結果
  • 簡介
  • 生物生產
  • 藥物研發
  • 毒性實驗
  • 組織工程
  • 其他

第9章 全球細胞株開發市場:各地區

  • 主要調查結果
  • 簡介
    • 細胞株開發市場評估:各地區,2020~2034年
  • 北美
    • 北美:各類產品·服務,2020~2034年
    • 北美:供給來源,2020~2034年
    • 北美:各細胞株類型,2020年~2034年
    • 北美:各用途,2020~2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各類產品·服務,2020~2034年
    • 歐洲:供給來源,2020~2034年
    • 歐洲:各細胞株類型,2020~2034年
    • 歐洲:各用途,2020~2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各類產品·服務,2020年~2034年
    • 亞太地區:供給來源,2020~2034年
    • 亞太地區:各細胞株類型,2020年~2034年
    • 亞太地區:各用途,2020~2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各類產品·服務,2020~2034年
    • 中東·非洲:供給來源,2020~2034年
    • 中東·非洲:各細胞株類型,2020~2034年
    • 中東·非洲:各用途,2020~2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:各類產品·服務,2020~2034年
    • 南美:供給來源,2020~2034年
    • 南美:各細胞株類型,2020年~2034年
    • 南美:各用途,2020~2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第10章 競爭情形

  • 事業擴大·收購分析
    • 事業擴大
    • 收購
  • 聯盟/合作/協定/公開

第11章 企業簡介

  • Advanced Instruments
  • Berkeley Lights
  • Cellistic
  • Charles River Laboratories
  • Creative Biolabs
  • Cytovance Biologics
  • Danaher Corporation
  • Lonza Group AG
  • Merck KGaA
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • WuXi Biologics
Product Code: PM6117

The cell line development market size is expected to reach USD 15.43 billion by 2034, according to a new study by Polaris Market Research. The report "Cell Line Development Market Share, Size, Trends, Industry Analysis Report: By Product & Service, By Source, By Type of Cell Lines, By Application, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Cell line development includes generation and selection of stable cell lines for biologics production, vaccine development and for drug screening purposes that ensure high productivity, genetic stability, and consistent therapeutic output. The market continues to expand as pharmaceutical and biotechnology companies increasingly adopt advanced cell line engineering technologies to accelerate biologics development, reduce production costs, and improve product quality.

The market growth is fueled by the rising global demand for recombinant proteins and cell-based vaccines. Increasing R&D expenditure in oncology, infectious diseases, and personalized medicine is boosting the adoption of innovative cell line engineering techniques, including CRISPR gene editing and single-use bioreactors. Additionally, growing investments in biopharmaceutical manufacturing infrastructure and strategic outsourcing partnerships with specialized CDMOs are helping large-scale production of therapeutic biologics worldwide.

Cell Line Development Market Report Highlights

Based on product and service, the reagents & media segment accounted for the largest market share in 2024, due to the rising demand for high-quality, chemically defined media that enhance cell growth, stability, and productivity in biologics manufacturing.

Based on source, the mammalian cell line segment dominated the market, driven by its high efficiency in producing complex therapeutic proteins that ensures better efficacy and safety in biologics manufacturing.

Based on type of cell lines, the hybridomas segment is expected to witness the fastest growth, fueled by increasing demand for monoclonal antibody production in oncology, autoimmune, and infectious disease therapeutics, along with advancements in hybridoma screening and selection techniques.

Based on application, the bioproduction segment held the dominant share in 2024, due to the rising adoption of stable cell lines for large-scale manufacturing of recombinant proteins, biosimilars, and vaccines.

North America dominated the global cell line development market in 2024, fueled by advanced manufacturing infrastructure, and the presence of leading biotechnology firms and CDMOs.

Asia Pacific witnessed a steady growth, driven by rapid expansion of the regional biopharmaceutical industry and increasing outsourcing of cell line development services to cost-efficient markets such as China and India.

A few global key market players include Lonza Group AG, WuXi Biologics, Thermo Fisher Scientific Inc., Sartorius AG, Charles River Laboratories, Merck KGaA, Cytovance Biologics, Cellistic, Berkeley Lights, Advanced Instruments, Danaher Corporation, and Creative Biolabs.

Polaris Market Research has segmented the market report on the basis of product & service, source, type of cell lines, application, and region:

By Product & Service Outlook (Revenue, USD Billion, 2020-2034)

Reagent and Media

Equipment

Automated Systems

Centrifuges

Bioreactors

Storage Equipment

Others

Accessories and Consumables

Services

By Source Outlook (Revenue, USD Billion, 2020-2034)

Mammalian Cell Line

Non-Mammalian Cell Line

Insects

Amphibians

By Type of Cell Lines (Revenue, USD Billion, 2020-2034)

Recombinant Cell Lines

Hybridomas

Continuous Cell Lines

Primary Cell Lines

By Application (Revenue, USD Billion, 2020-2034)

Bioproduction

Drug Discovery

Toxicity Testing

Tissue Engineering

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cell Line Development Market Insights

  • 4.1. Cell Line Development Market - Market Snapshot
  • 4.2. Cell Line Development Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Cases of Cancer Worldwide
      • 4.2.1.2. Rising Global R&D Expenditure
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost and time-intensive development process
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cell Line Development Market Trends
  • 4.6. Value Chain Analysis

5. Global Cell Line Development Market, by Product & Service

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • 5.3. Reagent and Media
    • 5.3.1. Global Cell Line Development Market, by Reagent and Media, by Region, 2020-2034 (USD Billion)
  • 5.4. Equipment
    • 5.4.1. Global Cell Line Development Market, by Equipment, by Region, 2020-2034 (USD Billion)
  • 5.5. Accessories and Consumables
    • 5.5.1. Global Cell Line Development Market, by Accessories and Consumables, by Region, 2020-2034 (USD Billion)
  • 5.6. Toxicity Testing
      • 5.6.1.1. Global Cell Line Development Market, by Toxicity Testing, by Region, 2020-2034 (USD Billion)

6. Global Cell Line Development Market, by Source

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • 6.3. Mammalian Cell Line
    • 6.3.1. Global Cell Line Development Market, by Mammalian Cell Line, by Region, 2020-2034 (USD Billion)
  • 6.4. Non-Mammalian Cell Line
    • 6.4.1. Global Cell Line Development Market, by Non-Mammalian Cell Line, by Region, 2020-2034 (USD Billion)

7. Global Cell Line Development Market, by Type of Cell Lines

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • 7.3. Recombinant Cell Lines
    • 7.3.1. Global Cell Line Development Market, by Recombinant Cell Lines, by Region, 2020-2034 (USD Billion)
  • 7.4. Hybridomas
    • 7.4.1. Global Cell Line Development Market, by Hybridomas, by Region, 2020-2034 (USD Billion)
  • 7.5. Continuous Cell Lines
    • 7.5.1. Global Cell Line Development Market, by Continuous Cell Lines, by Region, 2020-2034 (USD Billion)
  • 7.6. Primary Cell Lines
    • 7.6.1. Global Cell Line Development Market, by Primary Cell Lines, by Region, 2020-2034 (USD Billion)

8. Global Cell Line Development Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • 8.3. Bioproduction
    • 8.3.1. Global Cell Line Development Market, by Bioproduction, by Region, 2020-2034 (USD Billion)
  • 8.4. Drug Discovery
    • 8.4.1. Global Cell Line Development Market, by Drug Discovery, by Region, 2020-2034 (USD Billion)
  • 8.5. Toxicity Testing
    • 8.5.1. Global Cell Line Development Market, by Toxicity Testing, by Region, 2020-2034 (USD Billion)
  • 8.6. Tissue Engineering
    • 8.6.1. Global Cell Line Development Market, by Tissue Engineering, by Region, 2020-2034 (USD Billion)
  • 8.7. Others
    • 8.7.1. Global Cell Line Development Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Cell Line Development Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Cell Line Development Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Cell Line Development Market - North America
    • 9.3.1. North America: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
    • 9.3.2. North America: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
    • 9.3.3. North America: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
    • 9.3.4. North America: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.3.5. Cell Line Development Market - U.S.
      • 9.3.5.1. U.S.: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.3.5.2. U.S.: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.3.5.3. U.S.: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.3.5.4. U.S.: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.3.6. Cell Line Development Market - Canada
      • 9.3.6.1. Canada: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • 9.4. Cell Line Development Market - Europe
    • 9.4.1. Europe: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.4.5. Cell Line Development Market - UK
      • 9.4.5.1. UK: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.4.6. Cell Line Development Market - France
      • 9.4.6.1. France: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.4.7. Cell Line Development Market - Germany
      • 9.4.7.1. Germany: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.4.8. Cell Line Development Market - Italy
      • 9.4.8.1. Italy: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.4.9. Cell Line Development Market - Spain
      • 9.4.9.1. Spain: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.4.10. Cell Line Development Market - Netherlands
      • 9.4.10.1. Netherlands: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.4.11. Cell Line Development Market - Russia
      • 9.4.11.1. Russia: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.4.12. Cell Line Development Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • 9.5. Cell Line Development Market - Asia Pacific
    • 9.5.1. Asia Pacific: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.5.5. Cell Line Development Market - China
      • 9.5.5.1. China: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.5.6. Cell Line Development Market - India
      • 9.5.6.1. India: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.5.7. Cell Line Development Market - Malaysia
      • 9.5.7.1. Malaysia: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.5.8. Cell Line Development Market - Japan
      • 9.5.8.1. Japan: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.5.9. Cell Line Development Market - Indonesia
      • 9.5.9.1. Indonesia: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.5.10. Cell Line Development Market - South Korea
      • 9.5.10.1. South Korea: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.5.11. Cell Line Development Market - Australia
      • 9.5.11.1. Australia: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.5.12. Cell Line Development Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • 9.6. Cell Line Development Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.6.5. Cell Line Development Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.6.6. Cell Line Development Market - UAE
      • 9.6.6.1. UAE: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.6.7. Cell Line Development Market - Israel
      • 9.6.7.1. Israel: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.6.8. Cell Line Development Market - South Africa
      • 9.6.8.1. South Africa: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.6.9. Cell Line Development Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • 9.7. Cell Line Development Market - Latin America
    • 9.7.1. Latin America: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.7.5. Cell Line Development Market - Mexico
      • 9.7.5.1. Mexico: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.7.6. Cell Line Development Market - Brazil
      • 9.7.6.1. Brazil: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.7.7. Cell Line Development Market - Argentina
      • 9.7.7.1. Argentina: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
    • 9.7.8. Cell Line Development Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Cell Line Development Market, by Application, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Advanced Instruments
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product & Service Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Berkeley Lights
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product & Service Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Cellistic
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product & Service Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Charles River Laboratories
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product & Service Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Creative Biolabs
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product & Service Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Cytovance Biologics
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product & Service Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Danaher Corporation
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product & Service Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Lonza Group AG
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product & Service Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Merck KGaA
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product & Service Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Sartorius AG
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product & Service Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Thermo Fisher Scientific Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product & Service Benchmarking
    • 11.11.4. Recent Development
  • 11.12. WuXi Biologics
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product & Service Benchmarking
    • 11.12.4. Recent Development

List of Tables:

  • Table 1 Global Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 2 Global Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 3 Global Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 4 Global Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 5 North America: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 6 North America: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 7 North America: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 8 North America: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 9 U.S.: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 10 U.S.: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 11 U.S.: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 12 U.S.: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 13 Canada: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 14 Canada: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 15 Canada: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 16 Canada: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 17 Europe: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 18 Europe: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 19 Europe: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 20 Europe: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 21 UK: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 22 UK: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 23 UK: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 24 UK: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 25 France: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 26 France: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 27 France: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 28 France: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 29 Germany: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 30 Germany: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 31 Germany: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 32 Germany: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Italy: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 34 Italy: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 35 Italy: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 36 Italy: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 37 Spain: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 38 Spain: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 39 Spain: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 40 Spain: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 45 Russia: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 46 Russia: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 47 Russia: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 48 Russia: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 57 China: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 58 China: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 59 China: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 60 China: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 61 India: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 62 India: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 63 India: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 64 India: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Japan: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 70 Japan: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 71 Japan: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 72 Japan: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 77 South Korea: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 78 South Korea: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 79 South Korea: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 80 South Korea: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 81 Australia: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 82 Australia: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 83 Australia: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 84 Australia: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 97 UAE: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 98 UAE: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 99 UAE: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 100 UAE: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 101 Israel: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 102 Israel: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 103 Israel: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 104 Israel: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 105 South Africa: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 106 South Africa: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 107 South Africa: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 108 South Africa: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 113 Latin America: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 114 Latin America: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 115 Latin America: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 116 Latin America: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 117 Mexico: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 118 Mexico: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 119 Mexico: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 120 Mexico: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 121 Brazil: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 122 Brazil: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 123 Brazil: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 124 Brazil: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 125 Argentina: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 126 Argentina: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 127 Argentina: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 128 Argentina: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Cell Line Development Market, by Application, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Cell Line Development Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product & Service
  • Figure 7. Global Cell Line Development Market, by Product & Service, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Source
  • Figure 9. Global Cell Line Development Market, by Source, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Type of Cell Lines
  • Figure 11. Global Cell Line Development Market, by Type of Cell Lines, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Application
  • Figure 13. Global Cell Line Development Market, by Application, 2024 & 2034 (USD Billion)